Why the study?
Does continuing antiplatelet therapy increase the risk of complications in patients undergoing cataract surgery?
Population
60 phacoemulsification procedures in patients undergoing cataract surgery
Comparison
Continued antiplatelet therapy prior to and… vs No medications with antiplatelet activity prior…
Design
Cohort
Authors
Loading...
Continuing antiplatelet therapy was associated with more minor hemorrhages but no acuity or IOP differences; leaves open serious bleeding risks and practice implications.
Does continuing antiplatelet therapy increase the risk of complications in patients undergoing cataract surgery?
Continuing antiplatelet therapy during cataract surgery increases the risk of minor subconjunctival hemorrhages but does not adversely affect visual acuity or intraocular pressure, though the study was underpowered for rare serious bleeding events.
Shuler et al. (1992) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: